Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma - Wikidata - awgldk - TriplyDB

Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma

Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma

http://www.wikidata.org/entity/Q36545163

about

An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma Current diagnostic and management options in perihilar cholangiocarcinoma Cancer review: Cholangiocarcinoma Cholangiocarcinoma Cholangiocarcinoma: Current Knowledge and New Developments Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis?Targeted therapy in biliary tract cancers-current limitations and potentials in the future.Platelet-derived growth factor primes cancer-associated fibroblasts for apoptosis.Molecular pathogenesis of cholangiocarcinoma.Pathogenesis, diagnosis, and management of cholangiocarcinoma Periostin in intrahepatic cholangiocarcinoma: pathobiological insights and clinical implications.Cholangiocarcinoma: molecular pathways and therapeutic opportunities Fibroblast-Derived Exosomes Contribute to Chemoresistance through Priming Cancer Stem Cells in Colorectal Cancer.Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach.Stromal Myofibroblasts Are Associated with Poor Prognosis in Solid Cancers: A Meta-Analysis of Published Studies Bone mesenchymal stem cells differentiate into myofibroblasts in the tumor microenvironment.Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer.Multidisciplinary approaches to intrahepatic cholangiocarcinoma.Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting.Moving receptor redirected adoptive cell therapy toward fine tuning of antitumor responses.Priming cancer cells for drug resistance: role of the fibroblast niche.New Horizons for Precision Medicine in Biliary Tract Cancers.Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).Heralding a new paradigm in 3D tumor modeling.Using real-time impedance-based assays to monitor the effects of fibroblast-derived media on the adhesion, proliferation, migration and invasion of colon cancer cells.Unveiling the role of tumor reactive stroma in cholangiocarcinoma: an opportunity for new therapeutic strategies.Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness.Sorafenib for the treatment of solid malignancies: what about the cancer microenvironment?Targeting tumor stroma: exploiting apoptotic priming.Extracellular vesicles carry microRNA-195 to intrahepatic cholangiocarcinoma and improve survival in a rat model.Transforming Growth Factors α and β Are Essential for Modeling Cholangiocarcinoma Desmoplasia and Progression in a Three-Dimensional Organotypic Culture Model.Cholangiocarcinoma - evolving concepts and therapeutic strategies.Overexpression of α-sma-positive fibroblasts (CAFs) in Nasopharyngeal Carcinoma Predicts Poor Prognosis.Targeting senescent cholangiocytes and activated fibroblasts with B-cell lymphoma-extra large inhibitors ameliorates fibrosis in multidrug resistance 2 gene knockout (Mdr2-/- ) mice.The microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells.The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer.Platelet-derived growth factor D: a new player in the complex cross-talk between cholangiocarcinoma cells and cancer-associated fibroblasts.Understanding liver regeneration to bring new insights to the mechanisms driving cholangiocarcinoma.Targeting cholangiocarcinoma.Therapie des metastasierten Cholangiokarzinoms

P2860

Q26784091-3704AD0E-62DC-40E1-9D37-B3D04D4D7417 Q26822808-4333F903-DA58-42D4-8A9C-9CAB0E0359EF Q26865200-F911706A-406C-49DF-9214-AD64B665DC76 Q27001694-1C9D5962-455C-462E-A316-57A262934981 Q28076098-65559D79-0376-4501-8062-C68DBCDE9CA5 Q28084572-B49F571B-1622-4038-A2D4-7F39B8AAAFE7 Q30234532-7161AE94-026C-42F9-9F7B-26683CCFAE37 Q34044638-3B5AEFB7-4FAF-4DB6-A414-371620EEC647 Q34065560-FC506779-D789-43F2-85D0-50784401C4A6 Q34656747-11277B34-7D14-4173-9F37-84CA3A29317E Q34673957-738C3F24-D0F5-4DD6-998C-64E311A62534 Q34959174-88574312-FC08-4C7E-82F8-518DDCE86903 Q35566486-B74FBBD2-30D2-4EB9-8447-35E85382CD54 Q35594611-C0DDE97E-2214-4FB4-9C95-DCC8FE3726EC Q36086002-D4F36C46-76AF-4C23-8F28-B2764591EC5F Q37002808-9C4C593E-71EC-4A39-85E7-F506BE1E9406 Q37746078-5CA9F698-C268-475C-9366-2FC32901D28D Q38130469-0A424611-3561-4C4F-94B7-67B33A8AA44F Q38152382-35CE2155-2ACB-44BD-B35D-342A73A80B20 Q38218786-688A91C5-37A0-43A2-8E08-EC0C66AE9C1C Q38232067-AD5B6243-D162-4C56-B4B4-D417F381E615 Q38619219-21EFE339-2575-4851-AFEC-B8F3BE92044C Q38812588-E7024BD4-6B1D-4847-BB15-77228DC08FE2 Q38957511-2BD7A5EC-9577-4FB3-B2C0-11BF96B6A230 Q38984111-1A11F57B-8D7C-4DB1-91CE-F4B988611B32 Q42272472-0B99839F-0CFB-4F0C-A77E-70BEF2FDBDEF Q42371988-82C88969-D1A4-44B8-B14C-23E29618F0A3 Q42931526-AD49D85C-C9A5-4742-AB67-8B0E517102A0 Q43127374-13F009B7-C3CB-40F5-A4F3-C54B4318080C Q45039242-F2B0797C-6279-4E0A-A10F-98459BCF1EF1 Q45055057-F25CEEC7-D922-4B6E-810B-D1E305EAEBE8 Q46087686-74F0E694-793E-4985-B6D8-FCED00880FD4 Q47153062-DF42B044-3844-4B22-8B5D-0BC718907D21 Q47961293-5CE079F6-035A-4967-BC7C-DF146EA2A909 Q48217057-9B08F0D0-7EAF-41CC-B7BB-0FD3526CEA5D Q50350640-7088558E-AA5C-47EB-87DE-D0FAD27BB157 Q50972322-964B7707-A378-40E1-BED6-0CF6DECEF594 Q52729640-6FC0E62D-A735-4EFC-9CE7-D1EFBA1A0B5D Q52757760-06B9E2E0-3938-48CD-89C5-39C9B55BCAA8 Q57074642-0FC32565-980F-4959-98CE-7E286FA685DF

P2860

Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma

http://www.wikidata.org/entity/Q36545163

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma

@ast

Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma

@en

type

label

Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma

@ast

Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma

@en

prefLabel

Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma

@ast

Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma

@en

P1433

Q36545163-FF9578D2-565D-4274-979A-60FDBADE51B3

P1476

Q36545163-B86E417F-CB61-4D02-8175-D88DA5C459C9

P2093

Q36545163-1BE429D6-36E3-49CA-894F-74DF7EBDF46F

Q36545163-37A3A57A-BA26-4B0E-88DB-7D2FC796B213

Q36545163-53D8ADEE-10F0-4046-B0B8-F5A2F0F96165

Q36545163-69D134FA-5829-4BE5-A07E-E0FF96DD9D9E

Q36545163-A460EE31-E3F3-4097-9F38-4FBCE83267BF

Q36545163-E0E6A554-4848-469B-9636-0910FC656A84

Q36545163-E833A056-9CF1-4B45-9E78-E78E68D21F24

P2860

Q36545163-03BC9B03-FBDB-4D5B-936B-97B09F5BBC0A

Q36545163-15BC7231-4553-4856-BE51-CD2E28FF09C8

Q36545163-183D15E7-DE3E-4AE3-8183-4622B9725231

Q36545163-1FC00126-8A7D-4122-A9B3-D3974952ED02

Q36545163-2A31515E-CAD3-4A9A-9A06-23B31B86FFDB

Q36545163-398960D4-BC2A-42EE-A925-B2905C8E49EF

Q36545163-3F5569A2-C3CE-41EA-93E9-D94E7334799F

Q36545163-45AC4AFD-56B2-41E1-A1EE-82113C8E6366

Q36545163-474353EB-065F-47D6-A627-7E143E4B6BD7

Q36545163-499301ED-A5BB-48F0-BA06-818B276D5FED

P304

Q36545163-56207050-6FDD-4F5E-B2B2-D487E88E09DF

P31

Q36545163-715C1C05-05B5-44FA-8181-567CE74AA6EF

P356

Q36545163-1EBB286D-4CCB-4E6A-A177-119F5D6CC8E0

P407

Q36545163-03BEC22C-9362-4DD1-935C-B3BC1E0FECEC

P433

Q36545163-DAA8B955-E752-4689-AFF0-305A8BABA671

P478

Q36545163-61C9E4E1-BF17-44F5-ADE0-76ECDA968E48

P50

Q36545163-4FA93659-300E-4D68-AE45-A36675F71124

Q36545163-621B89D4-7CCB-4ED1-820D-9556DE92434E

Q36545163-7C84D573-DF40-460D-8794-9ABEE557597E

Q36545163-FD07DB23-FD04-4716-8FC6-642508032711

P577

Q36545163-44EC27C7-3541-4699-B08D-53C6BC429F3A

P698

Q36545163-99791B76-3F76-48E9-AE54-4A8EEE66C548

P921

Q36545163-CC8CC6B3-B156-4914-8DC5-657DB9C6FB3D

P932

Q36545163-7834C1CC-274D-46EC-BE12-DEEE38A1AFE2

P356

0008-5472.CAN-12-2130

P1433

Cancer Research

P1476

Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma

@en

P2093

Alphonse E Sirica

http://www.w3.org/2001/XMLSchema#string

Christian D Fingas

http://www.w3.org/2001/XMLSchema#string

John D Christensen

http://www.w3.org/2001/XMLSchema#string

Michael P Gustafson

http://www.w3.org/2001/XMLSchema#string

Nathan W Werneburg

http://www.w3.org/2001/XMLSchema#string

Rory L Smoot

http://www.w3.org/2001/XMLSchema#string

Steven F Bronk

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

Fibroblasts in cancer

Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs

Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.

Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1.

Tenascin-C enhances pancreatic cancer cell growth and motility and affects cell adhesion through activation of the integrin pathway

VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization.

Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737.

P304

897-907

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-12-2130

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P50

Lewis R. Roberts

Joachim C. Mertens

Gregory J Gores

P577

2012-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23221385

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

P932

3549008

http://www.w3.org/2001/XMLSchema#string